Clinical Research Directory
Browse clinical research sites, groups, and studies.
NK-ORB Expression of Mu Receptor on Lymphocytes in Rehabilitation
Sponsor: IRCCS San Raffaele Roma
Summary
Chronic pain is a serious disorder that causes physical suffering and emotional distress. NK cells are cytotoxic granular cells playing a crucial role in innate immunity. Recent studies described modulation of the percentage of B lymphocytes and NK cells expressing the μ opioid receptor as a potential marker for measuring pain. Neuropathic pain sufferers have decreased NK cell function, highlighting the need of further investigating the effect of opioid receptor expression on lympoid cells defining their potential relevance as a pain monitor marker. Opioid receptors expressed on NK, B and T cells are a possible candidate for objective monitoring of pain in patients.
Official title: Employment of Natural Killer Opioid Receptor as a Biomarker to Ameliorate the Efficacy of the Rehabilitation Program in a Patient-oriented Strategy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-10-03
Completion Date
2026-04-29
Last Updated
2024-06-13
Healthy Volunteers
Not specified
Conditions
Interventions
Rehabilitation
3-weeks rehabilitation in hospital
Locations (1)
IRCCS San Raffaele
Roma, Italy